Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
2.74 HKD | +2.24% | +11.38% | -21.04% |
15:19 | Sino Biopharm schließt Phase-I-Studie für Hepatitis-B-Medikament ab | MT |
22.04. | Beruhigung der geopolitischen Spannungen beflügelt asiatische Aktienmärkte | MT |
ETFs investiert in Sino Biopharmaceutical Limited
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
2,40% | 2 M€ | -18.13% | - | |
2,02% | 4 M€ | -27.92% | ||
0,82% | 3 M€ | -2.93% | - | |
0,49% | 4 M€ | -11.56% | ||
0,48% | 18 M€ | +2.98% | ||
0,14% | 11 M€ | +0.55% | ||
0,13% | 35 M€ | -5.85% | - | |
0,10% | 1 M€ | +3.49% | - | |
0,10% | 3 M€ | -.--% | - | |
0,07% | 117 M€ | +0.16% | - | |
0,06% | 441 M€ | +3.59% | - | |
0,06% | 2 808 M€ | +4.23% | - | |
0,06% | 149 M€ | +0.93% | - | |
0,05% | 4 M€ | -4.41% | - | |
0,03% | 0 M€ | 0.00% | - | |
0,02% | 31 M€ | +2.71% | - | |
0,01% | 389 M€ | +4.94% | - | |
0,01% | 34 M€ | +5.94% | - | |
0,01% | 108 M€ | +1.18% | - | |
0,01% | 39 M€ | +3.93% | - | |
0,01% | 302 M€ | +2.88% | - | |
0,01% | 17 M€ | +1.15% | - | |
0,01% | 52 M€ | -1.18% | - | |
0,01% | 7 M€ | +1.38% | - | |
0,01% | 8 M€ | -0.85% | - | |
0,01% | 34 M€ | +2.22% | - |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-21.04% | 6.27 Mrd. | |
+24.17% | 562 Mrd. | |
-6.33% | 358 Mrd. | |
+19.90% | 322 Mrd. | |
+7.95% | 297 Mrd. | |
+13.45% | 219 Mrd. | |
+6.04% | 199 Mrd. | |
-10.51% | 196 Mrd. | |
-12.26% | 149 Mrd. | |
-6.47% | 146 Mrd. |
- Börse
- Aktien
- A0CBDJ Aktie
- ETFs Sino Biopharmaceutical Limited